Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD).

Toby M MaherShervin AssassiArata AzumaVincent CottinAnna-Maria Hoffmann-VoldMichael KreuterJustin M OldhamLuca Richeldi Claudia ValenzuelaMarlies S WijsenbeekCarl CoeckChristina SchleckerFlorian VossDaniel WachtlinFernando J Martinez

Published in: BMJ open respiratory research (2023)

NCT05321082.

Keyphrases

double blind
phase iii
pulmonary fibrosis
placebo controlled
clinical trial
interstitial lung disease
multiple sclerosis
phase ii
study protocol
systemic sclerosis
open label
idiopathic pulmonary fibrosis